Previous 10 | Next 10 |
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 08/7/2020. Please visit our Tracking Ole Andreas Halvorsen&...
GAITHERSBURG, Md., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases, today announced that four abstracts have been accepte...
The following slide deck was published by Viela Bio, Inc. in conjunction with their 2020 Q2 earnings Read more ...
Viela Bio, Inc. (VIE) Q2 2020 Earnings Conference Call August 12, 2020 17:00 ET Company Participants Mitchell Chan - Chief Financial Officer Bing Yao - Chairman and Chief Executive Officer Jörn Drappa - Chief Medical Officer and Head, R&D Bill Ragatz - Vice President a...
Image source: The Motley Fool. Viela Bio Inc (NASDAQ: VIE) Q2 2020 Earnings Call Aug 12, 2020 , 5:00 p.m. ET Operator Continue reading
VIELA BIO (NASDAQ: VIE ) : Q2 GAAP EPS of -$0.74 beats by $0.32 . More news on: Viela Bio, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
GAITHERSBURG, Md., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases, today reported financial results and provided program ...
GAITHERSBURG, Md., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases, today announced it will host a webcast and conference ...
Biotech has outpaced nearly every other sector this year in growth. While the S&P 500 was down 3.6% for the year as of Wednesday, the NASDAQ Biotechnology Index (NBI) is up 10.5% in 2020. That growth carries an enormous amount of risk, however, as many biotech companies aren't mak...
Viela Bio Wins FDA Approval for Autoimmune Treatment Viela Bio ( VIE ) reported that the FDA has given its nod for Uplizna or inebilizumab-cdon for treating adult patients suffering from neuromyelitis optica spectrum disorder who are anti-AQP4 antibody positive. It is estimated that near...
News, Short Squeeze, Breakout and More Instantly...
> A three-year partnership that aligns with Veolia’s mission to support organizations and industries that want to become more environmentally sustainable > Veolia will start with focusing on improving waste collection, increasing recycling percentages, providing sustainable w...
Clean Earth will partner with Veolia North America on a five-year agreement to provide guaranteed incineration capacity in a new state-of-the-art waste treatment facility in Gum Springs, Ark. The agreement provides reliable, predictable, safe, and efficient waste disposal for Clean Ea...
The array will produce over 250 million kilowatt hours of electricity – enough to power 25,000 homes – and offset carbon output by 105,000 tons over the next 25 years, making it the only hazardous waste treatment facility in U.S. to be fully energy self-sufficient Veolia N...